Home › Kanser sa Cervix › Texas › Dallas

Pag-aaral pangklinika para sa Kanser sa Cervix sa Dallas, TX

Isang pag-aaral para sa Kanser sa Cervix ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Dallas. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

DESTINY-PANTUMOUR04

Nagre-recruitObservasyonal na pag-aaral

Research Site, Dallas

Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07124000

Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

Nagre-recruitPhase 4

Parkland Health & Hospital System, Dallas
University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
University of Texas Southwestern Medical Center-William P. Clements Jr. University Hospital, Dallas
at 2 pa

Edad 18 pataas · Kababaihan · Na-update Set 25, 2026 · NCT06952660

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Nagre-recruitPhase 1/2

Baylor, Scott and White Research Institute, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06047379

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

Nagre-recruitPhase 1

Normunity Investigational Site, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT07182149

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Nagre-recruitPhase 1/2

Texas Oncology, P.A., Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 5, 2026 · NCT06330064

A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer

Nagre-recruit

Texas Oncology- Baylor Charles A. Sammons Cancer Center, Dallas
University of Texas Southwestern Medical Center-Simmons Cancer Center, Dallas
University of Texas Southwestern Medical Center-WIlliam P. Clements Jr. University Hospital, Dallas
at 2 pa

Edad 18 pataas · Kababaihan · Na-update Hul 30, 2026 · NCT04831580

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Nagre-recruitPhase 1/2

Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas
University of Texas Southwestern, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 7, 2026 · NCT05768139

Study of Pembrolizumab and Lenvatinib in Metastatic and Recurrent Cervix Cancer (LenPem Cervix)

Nagre-recruitPhase 2

UT Southwestern Medical Center, Dallas

Edad 18 pataas · Kababaihan · Na-update May 6, 2026 · NCT06266338

A Study of VET3-TGI in Patients With Solid Tumors

Nagre-recruitPhase 1

Mary Crowley Cancer Research, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 7, 2026 · NCT06444815

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

Nagre-recruitPhase 1

Dren Investigational Site, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Ene 7, 2026 · NCT06999187

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Nagre-recruitPhase 1/2

Research Site 120, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 21, 2025 · NCT05914116

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral

Massive Bio SYNERGY-AI site, Dallas

Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

Nagre-recruitPhase 1/2

Mary Crowley Cancer Research, Dallas
University of Texas Southwestern Medical Center, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2025 · NCT05941507

Pag-aaral para sa Kanser sa Cervix sa ibang lungsod

Iba pang pag-aaral sa Dallas

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.